학술논문
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
Document Type
Article
Author
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 16 November 2023, 389(20):1851-1861)
Subject
Language
English
ISSN
15334406
00284793
00284793